Weight-loss jab Wegovy to be offered on NHS for people at risk of further heart attacks

Importantly, benefits were seen early in the clinical trial, before significant weight loss occurred, suggesting the drug works directly on the heart and blood vessels, not just through weight loss, says NICE (the National Institute for Health and Care Excellence).